Free Trial

Labcorp (LH) Competitors

Labcorp logo
$276.37 +2.28 (+0.83%)
As of 11:37 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

LH vs. HOLX, HSIC, MEDP, AMN, CAH, CHE, DGX, MCK, TMO, and WST

Should you be buying Labcorp stock or one of its competitors? The main competitors of Labcorp include Hologic (HOLX), Henry Schein (HSIC), Medpace (MEDP), AMN Healthcare Services (AMN), Cardinal Health (CAH), Chemed (CHE), Quest Diagnostics (DGX), McKesson (MCK), Thermo Fisher Scientific (TMO), and West Pharmaceutical Services (WST). These companies are all part of the "medical" sector.

Labcorp vs. Its Competitors

Hologic (NASDAQ:HOLX) and Labcorp (NYSE:LH) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends, media sentiment and valuation.

94.7% of Hologic shares are owned by institutional investors. Comparatively, 95.9% of Labcorp shares are owned by institutional investors. 1.9% of Hologic shares are owned by insiders. Comparatively, 0.8% of Labcorp shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Hologic has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500. Comparatively, Labcorp has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500.

In the previous week, Hologic had 6 more articles in the media than Labcorp. MarketBeat recorded 21 mentions for Hologic and 15 mentions for Labcorp. Labcorp's average media sentiment score of 1.36 beat Hologic's score of 1.27 indicating that Labcorp is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hologic
14 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Labcorp
12 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hologic presently has a consensus price target of $78.00, suggesting a potential upside of 22.05%. Labcorp has a consensus price target of $290.33, suggesting a potential upside of 5.31%. Given Hologic's higher possible upside, research analysts plainly believe Hologic is more favorable than Labcorp.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hologic
0 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.59
Labcorp
1 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.62

Hologic has higher earnings, but lower revenue than Labcorp. Hologic is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hologic$4.03B3.53$789.50M$2.4126.52
Labcorp$13.01B1.76$746M$9.0630.43

Hologic has a net margin of 13.79% compared to Labcorp's net margin of 5.66%. Hologic's return on equity of 19.69% beat Labcorp's return on equity.

Company Net Margins Return on Equity Return on Assets
Hologic13.79% 19.69% 10.82%
Labcorp 5.66%15.45%7.02%

Summary

Hologic beats Labcorp on 9 of the 17 factors compared between the two stocks.

Get Labcorp News Delivered to You Automatically

Sign up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LH vs. The Competition

MetricLabcorpMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$22.92B$7.59B$5.76B$21.55B
Dividend Yield1.05%2.86%5.88%3.49%
P/E Ratio30.4576.3876.5830.02
Price / Sales1.7636.71525.0052.09
Price / Cash12.2924.1937.1724.77
Price / Book2.867.2214.154.55
Net Income$746M$241.92M$3.29B$999.02M
7 Day Performance0.98%2.48%1.28%2.15%
1 Month Performance1.89%3.09%5.01%5.39%
1 Year Performance21.45%2.55%86.96%14.62%

Labcorp Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LH
Labcorp
4.6492 of 5 stars
$276.37
+0.8%
$290.33
+5.1%
+21.4%$22.97B$13.01B30.5070,000Positive News
HOLX
Hologic
4.9066 of 5 stars
$66.54
-0.3%
$78.00
+17.2%
-23.4%$14.80B$4.03B27.617,063Positive News
Analyst Downgrade
HSIC
Henry Schein
3.8954 of 5 stars
$67.74
-2.4%
$76.67
+13.2%
-2.1%$8.21B$12.67B21.8525,000Positive News
Analyst Revision
MEDP
Medpace
4.314 of 5 stars
$492.09
+1.0%
$412.73
-16.1%
+37.6%$13.82B$2.11B36.595,900Positive News
AMN
AMN Healthcare Services
4.3903 of 5 stars
$20.97
+0.6%
$28.25
+34.7%
-59.8%$803.61M$2.98B-2.702,968Short Interest ↓
CAH
Cardinal Health
4.9642 of 5 stars
$150.29
+0.5%
$165.93
+10.4%
+31.0%$35.89B$222.58B23.3057,700Positive News
CHE
Chemed
4.9972 of 5 stars
$464.58
-0.2%
$592.25
+27.5%
-22.7%$6.77B$2.51B23.8915,695Positive News
Short Interest ↓
DGX
Quest Diagnostics
4.7754 of 5 stars
$182.53
-0.5%
$186.00
+1.9%
+15.2%$20.41B$9.87B21.8656,000Positive News
MCK
McKesson
4.6022 of 5 stars
$696.53
+1.3%
$725.10
+4.1%
+33.2%$86.63B$359.05B27.7745,000Positive News
TMO
Thermo Fisher Scientific
4.9628 of 5 stars
$487.11
-1.1%
$589.38
+21.0%
-21.7%$183.94B$42.88B28.17125,000Positive News
WST
West Pharmaceutical Services
4.9916 of 5 stars
$253.30
+1.0%
$320.71
+26.6%
-13.0%$18.21B$2.89B37.9210,600Positive News
Analyst Forecast

Related Companies and Tools


This page (NYSE:LH) was last updated on 9/17/2025 by MarketBeat.com Staff
From Our Partners